Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol IR in Patients Awaiting Joint Replacement Surgery
NCT00361582Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Oct 2006
- Primary completion
- Aug 2007
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of tapentadol in osteoarthritis (OA) (4 arms), sponsored by Johnson & Johnson. Primary endpoint: Sum of Pain Intensity Difference at 5 days. Started Oct 2006; status: completed.
02
Drugs
tapentadol
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00361582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00361582.